Exploring How Viral Infections Affect People With Chronic Lung Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImperial College London

About this trial

Many people with chronic lung disease have disease flare-ups. It was previously believed that these were mainly caused by bacteria but recent evidence suggests that viruses could be an important trigger. This study will recruit volunteers with chronic lung disease and take samples both when well (at baseline) and during flare-ups (exacerbations) to better understand the role of viruses in triggering exacerbations and also how the immune response is affected. The researchers will follow the volunteers\' progress for up to two years. Whenever they get unwell they will take some samples (nose swabs, finger prick testing, phlegm sample) and post them to the researchers. Then, they will come in for a visit for more samples (blood tests, further swabs) and a review.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults with a physician confirmed diagnosis of chronic airway disease (e.g. COPD and bronchiectasis) according to established diagnostic criteria.

Disqualifiers

Inability to complete daily symptom diaries and/or attend for clinical assessments.

Exacerbation within 4 weeks of study recruitment and/or clinical instability at the time of recruitment.

Pregnancy.

Trial population

Patients with chronic lung disease under the care of respiratory teams at Royal Brompton and Harefield (NHS) Hospitals.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Respiratory viruses detection during exaccerbations

The percentage of chronic airway disease exacerbations where a respiratory virus is detected (with sub-classification of the specific viral subtypes).

Time frame
All exacerbations within a 24 month follow up period.

Secondary outcomes

1

Differences in symptoms between viral and non-viral exacerbations

Differences in magnitude of deterioration in symptoms (as measured by validated symptom score) between viral and non-viral exacerbations.

Time frame
All exacerbations within a 24 month follow up period.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.